On CNBC's “Mad Money Lightning Round,” Jim Cramer said Reddit, Inc. RDDT is “fabulous,” adding that he is not a seller.
According to a report last week, shareholder Advance Magazine Publishers, Inc. plans to establish a credit facility using its stake in the company. Yahoo Finance reported that the publishing company aims to make as much as $1.2 billion in a sale of 7.8 million shares for between $145.38 and $148.54 per share.
“I am concerned that many auto parts may be made in China, we don't know," Cramer said when asked about Aptiv PLC APTV. He recommended going with AutoZone AZO.
On Nov. 21, Guggenheim analyst Ronald Jewsikow maintained Aptiv with a Buy and lowered the price target from $87 to $73.
When asked about Recursion Pharmaceuticals, Inc. RXRX, he said, “Now, I think, at five, it's, it is worthwhile speculation.”
On Nov. 20, Needham analyst Gil Blum reiterated Recursion Pharmaceuticals with a Buy and maintained a price target of $11.
“Not enough specialty,” Cramer said when asked about ZoomInfo Technologies Inc. ZI. “Let's pass on that.”
On Nov. 12, ZoomInfo Technologies reported better-than-expected earnings for its third quarter.
Dow Inc. DOW is a “tough” one, the “Mad Money” host said. “If you don't have growth, and you sell at 21 times earnings, you're not going to be able to do anything.”
On Nov. 8, Piper Sandler analyst Charles Neivert maintained Dow with an Overweight rating and lowered the price target from $62 to $60.
Cramer said, “Accounting irregularities equal sell,” when asked about Super Micro Computer SMCI.
Super Micro Computer experienced a significant stock decline on Tuesday, after announcing the termination of two critical loan agreements with major financial institutions.
Price Action:
- Aptiv shares fell 3.2% to settle at $55.28 on Tuesday.
- Reddit shares fell 4.4% to close at $135.61.
- Recursion Pharmaceuticals shares declined 1.8% to close at $5.89.
- ZoomInfo shares gained 0.2% to close at $10.89.
- Dow shares fell 2.9% to settle at $44.54 on Tuesday.
- Super Micro Computer shares dipped 10.4% to settle at $34.43 during the session.
Read Next:
Photo: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.